The financial toxicity of treating cancer
World of DTC Marketing
JANUARY 4, 2022
billion in 2015 and $208.9 These cost estimates include cancer-attributable costs for medical services and oral prescription drugs. Pharma companies are aware that insurers will rarely say no to new cancer therapies, but increased scrutinization of early approvals is on the horizon. billion in 2020 (2020 U.S. population.
Let's personalize your content